Clinical Significance of the Translocation (11;14)(q13;q32) in Multiple Myeloma

References

• Hallek M, Leif P Bergsagel, Anderson K C. Multiple myeloma: increasing evidence for a multistep transformation process. [Review]. Blood 1998; 91: 3
   PubMed Web of Science ®Google Scholar
• Nishida K, Tamura A, Nakazawa N, Ueda Y, Abe T, Matsuda F, Kashima K, Taniwaki M. The Ig heavy chain gene is frequently involved in chromosomal translocations in multiple myeloma and plasma cell leukemia as detected by in situ hybridization. Blood 1997; 90: 526
   PubMed Web of Science ®Google Scholar
• BergsagelL P L, Chesi M, Brents L A, Kuehl W M. Translocations into IgH Switch Regions — The Genetic Hallmark of Multiple Myeloma. Blood 1995; 86: 223
   Web of Science ®Google Scholar
• Chesi M, Bergsagel P L, Brents L A, Smith C M, Gerhard D S, Kuehl W M. Dysregulation of cyclin D1 by translocation into an IgH gamma switch region in two multiple myeloma cell lines. Blood 1996; 88: 674
   PubMed Web of Science ®Google Scholar
• Chesi M, Nardini E, Brents L A, Schrock E, Ried T, Kuehl W M, Bergsagel P L. Frequent translocation t(4; 14) (p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3. Nature Genetics 1997; 16: 260
   PubMed Web of Science ®Google Scholar
• Chesi M, Bergsagel P L, Shonukan O O, Martelli M L, Brents L A, Chen T, Schrock E, Ried T, Kuehl V M. Frequent Dysregulation of the C-Maf Proto-Oncogene At 16q23 By Translocation to an Ig Locus in Multiple Myeloma. Blood 1998; 91: 4457
   PubMed Web of Science ®Google Scholar
• Chesi M, Nardini E, Lim R, Smith K, Kuehl W, Bergsagel P. The t(4;14) translocation in myeloma dysregulates both FGFR3 and a novel gene, MMSET, resulting in IgH/MMSET hybrid transcripts. Blood 1998; 92: 3025
   PubMed Web of Science ®Google Scholar
• Fonseca R, Witzig T E, Gertz M A, Kyle R A, Hoyer J D, Jalal S M, Greipp P R. Multiple Myeloma and the Translocation t(11;14)(q13;q32)- a Report On 13 Cases. British Journal of Haematology 1998; 101: 296
   PubMed Web of Science ®Google Scholar
• Dewald G W, Kyle R A, Hicks G A, Greipp P R. The Clinical Significance of Cytogenetic Studies in 100 Patients With Multiple Myeloma, Plasma Cell Leukemia, or Amyloidosis. Blood 1985; 66: 380
   PubMed Web of Science ®Google Scholar
• Kaplan E L, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457
   Web of Science ®Google Scholar
• Tricot G, Barlogie B, Jagannath S, Bracy D, Mattox S, Vesole D H, Naucke S, Sawyer J R. Poor prognosis in multiple myeloma is associated only with partial or complete deletions of chromosome 13 or abnormalities involving 11q and not with other karyotype abnormalities. Blood 1995; 86: 4250
   PubMed Web of Science ®Google Scholar
• Tricot G, Sawyer J R, Jagannath S, Desikan K R, Siegel D, Naucke S, Mattox S, Bracy D, Munshi N, Barlogie B. Unique role of cytogenetics in the prognosis of patients with myeloma receiving high-dose therapy and autotransplants. Journal of Clinical Oncology 1997; 15: 2659
   PubMed Web of Science ®Google Scholar
• Drach J, Zojer N, Königsberg R, Ackermann J, Giryes A, Kowatsch L, Schuster R, Gisslinger Heinz R, Ludwig H, Huber H. Cytogenetically Defined Subgroups Of Patients With Multiple Myeloma (Mm) Have Significantly Different Overall Survival Times. A Study Based On Interphase-Fish Analysis. Blood 1998; 92, Abstract #2944
   PubMed Web of Science ®Google Scholar
• Lai J L, Michaux L, Dastugue N, Vasseur F, Daudignon A, Facon T, Bauters F, Zandecki M. Cytogenetics in multiple myeloma: a multicenter study of 24 patients with t(11;14) (q13;q32) or its variant. Cancer Genetics & Cytogenetics 1998; 104: 133
   PubMed Web of Science ®Google Scholar
• Fonseca R, Ahmann G J, Juneau A L, Jalal S M, Dewald G W, Larson D M, Therneau T M, Gertz M A, Greipp P R. Cytogertetic Abnormalities In Systemic Amyloidosis; A Comparison Of Conventional Cytogenetic Analysis To Fluorescent In-Situ Hybridization With Simultaneous Cytoplasmic Immunoglobulin Staining (Meeting abstract). Blood 1997; 90(10)1559a
   Web of Science ®Google Scholar
• Avet-Loiseau H, Li J Y, Facon T, Brigaudeau C, Morineau N, Maloisel F, Rapp M J, Talmant P, Trimoreau F, Jaccard A, Harousseau J L, Bataille R. High incidence of translocations t(11;14)(q13;q32) and t(4;14)(p16;q32). Cancer Res 1998; 58: 5640
   PubMed Web of Science ®Google Scholar
• Nishida K, Seto M, Kashima K, Taniwaki M. A t(11;14)(q13;q32) Was Detected on Interphase Nuclei Of Myeloma Cells By DC-Fish With PRAD and IgH Gene Probes. Blood 1998; 92, Abstract
   PubMed Web of Science ®Google Scholar
• Chesi M, Bergsagel P L, Brents L A, Smith C M, Gerhard D S, Kuehl W M. Dysregulation of cyclin D 1 by translocation into an IgH gamma switch region in two multiple myeloma cell lines. Blood 1996; 88: 674
   PubMed Web of Science ®Google Scholar
• Hoyer J, Fonseca R, Greipp P, Hanson C, Kurtin P. The (11;14)(q13;q32) Translocation in Multiple Myeloma (MM): A Morphologic and Immunohistochemichal Study. Proceedings for the Annual Meeting of the United Staes and Canadian Academy of Pathology: Abstract. 1999
   Google Scholar
• Vasef M A, Medeiros L J, Yospur L S, Sun N C, McCourty A, Brynes R K. Cyclin D1 protein in multiple myeloma and plasmacytoma: an immunohistochemical study using fixed, paraffin-embedded tissue sections. Modern Pathology 1997; 10: 927
   PubMed Web of Science ®Google Scholar
• Kobayashi H, Saito H, Kitano K, Kiyosawa K, Gaun S, Aoki K, Narita A, Watanabe M, Uchimaru K, Motokura T. Overexpression Of The PRAD 1 Oncogene in a Patient With Multiple Myeloma and t(11;14)(q13;q32). Acta Haematologica. Acta Haematologica 1995; 94: 199
   PubMed Web of Science ®Google Scholar
• Zukerberg L R, Yang W I, Arnold A, Harris N L. Cyclin D expression in non-Hodgkin's lymphomas. Detection by immunohistochemistry. American Journal of Clinical Pathology 1995; 103: 756
   PubMed Web of Science ®Google Scholar
• Fonseca R, Hoyer J, Ahmann G, Vaandrager J, Schuuring E, Kluin P, Rajkumar S, Witzig T, Gertz M, Lust J, Lacy M, Kyle R, Dispenzieri A, Jalal S, Dewald G, Greipp P. The t(11;14)(q13;q32) Is Strongly Associated With Cyclin D Over-Expression In Bone Marrow Plasma Cells Of Multiple Myeloma (MM) Patients. Blood 1998; 92: 1068, Abstract
   Google Scholar
• Pratt G, Fenton J, Proffitt J, Rawstron A, Davies F, Child J, Morgan G. True Spectrum of 14q32 Translocations in Multiple Myeloma. British Journal of Haematology 1998; 103: 1209
   PubMed Web of Science ®Google Scholar